IONS
TYPE Stocks
GROUP Stocks
BASE Ionis Pharma...
SECOND US Dollar
<% (signals.list.current.rate).substr(0,7) %>
<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)
MARKETS TREND
OPEN
<% (signals.list.current.openrate).substr(0,9) %>
HIGH
<% (signals.list.current.high).substr(0,9) %>
LOW
<% (signals.list.current.low).substr(0,9) %>
IONS Signals
DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM
ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM
<% signal.pair %> (<% signal.rate %>) <% signal.action %>
<% signal.status %>
<% signal.analyst %><% signal.analyst %>
Long Term
Entry Price
Stop Loss
Take Profit
PREMIUM ONLY
<% signal.stopLoss %> N/A
PREMIUM ONLY
<% signal.takeProfit %> N/A
PREMIUM ONLY
<% signal.analyst %><% signal.analyst %>
<% signal.comment %>
Description
<% signal.description %>
LATEST ANALYSIS
<% item.time_ago %> Ago
<% item.title %>
<% item.deltaTime %>

Last Updated: Dec 24, 2025 01:14:21 PM (GMT)

IONS: The current market price is 80.15, reflecting a percentage change of approximately 0.18% from the previous close.

Support and Resistance Levels Current support levels are 79.49, 79.53, and 79.57; resistance levels are 80.15, 80.34, and 80.63. The pivot point is at 80.15.

Indicators RSI shows high values, indicating overbought conditions near 94.79. ATR is at 0.052, suggesting low price volatility, while ADX is steadily above 80, indicating a strong trend. SMA-50 and EMA-100 are both near 80.15, showing minimal price movement.

Market Sentiment A bearish scenario is predicted as the market price is at the pivot point of 80.15, and indicators suggest a potential correction. ---

IONS Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>
Market Trend
Strong Sell
Sell
Neutral
Buy
Strong Buy
Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>
Strong Sell
Sell
Neutral
Buy
Strong Buy

Trend Indicators

NAME
VALUE
ACTION
Bollinger Bands
UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>
MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>
LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>
Sell
Buy
Parabolic SAR
<% indicators.data[indicators.interval.active].sar.value %>
Sell
Buy
Standard Deviation
<% indicators.data[indicators.interval.active].stddev.value %>
High Volatility
Low Volatility

Oscillators

NAME
VALUE
ACTION
RSI(14)
<% indicators.data[indicators.interval.active].rsi.value %>
Sell
Buy
MACD(12,26)
<% indicators.data[indicators.interval.active].macd.value %>
Buy
Sell
Neutral
ATR
<% indicators.data[indicators.interval.active].atr.value %>
High Volatility
Low Volatility
STOCH(9,6)
<% indicators.data[indicators.interval.active].stochastics.value %>
Buy
Sell
ADX
<% indicators.data[indicators.interval.active].adx.value %>
High Volatility
Low Volatility

Moving Averages

PERIOD
SIMPLE
EXPONENTIAL
MA5
<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell
MA10
<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell
MA20
<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell
MA50
<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell
MA100
<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT
CLASSIC
FIBONACCI
CAMARILLA
WOODIE
S3
<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>
S2
<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>
S1
<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>
PP
<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>
R1
<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>
R2
<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>
R3
<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (IONS) Ionis Pharmaceuticals Inc.

Company Background

Ionis Pharmaceuticals Inc. (Ticker: IONS) is a pioneering biopharmaceutical company based in the United States, specialized in the discovery and development of RNA-targeted therapeutics. Established in 1989, Ionis has dedicated over three decades to advancing innovative treatments for a variety of diseases, including neurological disorders, cardiovascular diseases, and rare genetic conditions. The company employs its proprietary Ionis technology platform, which enables the creation of drugs that can precisely target and modulate RNA, offering a transformative approach to medicine.

Market Position

Ionis Pharmaceuticals holds a competitive edge in the biopharmaceutical industry, recognized for its scientific expertise and robust pipeline of drug candidates. The company strategically partners with major pharmaceutical firms, enhancing its reach and capacity to bring novel therapies to market. With an extensive portfolio of 48 drugs across various stages of development, including those targeting debilitating conditions like amyloidosis and Huntington's disease, Ionis is positioned as a leader in RNA-targeted therapies. Its focus on unmet medical needs underscores its commitment to improving patient outcomes globally.

Key Financial Highlights

Ionis Pharmaceuticals has demonstrated solid financial performance, bolstered by strategic collaborations and a diverse pipeline. As of the latest fiscal reports, the company has recorded significant revenue growth driven by its partnered programs and royalties from approved drugs like Spinraza, which have contributed to its financial stability. With a strong balance sheet and effective cost management, Ionis is well-equipped to invest in research and development, ensuring continued innovation. The company is also committed to delivering shareholder value through strategic initiatives and raising its market presence internationally.

Industry Highlights

The biopharmaceutical sector is experiencing rapid growth, propelled by advancements in personalized medicine and RNA therapeutics. Ionis Pharmaceuticals capitalizes on emerging trends, positioning itself to leverage new opportunities in the evolving healthcare landscape. As global demand for innovative treatments rises, Ionis is on the forefront, committed to transforming the future of medicine through cutting-edge technology and pioneering research.

Related Stocks

ALNY logo
ALNY
Alnylam Pharmaceuticals Inc.
0
Industry Biotechnology
Exchange NASDAQ
VRTX logo
VRTX
Vertex Pharmaceuticals Incorporated
0
Industry Biotechnology
Exchange NASDAQ
SLNO logo
SLNO
Soleno Therapeutics Inc.
0
Industry Biotechnology
Exchange NASDAQ

HFM

Pu Prime

XM

Best Forex Brokers